How time flies! Half of 2019 has gone. I wanted to talk more about my feelings, but I’m a "feelingless" writer, so, may you achieve your goal for 2019 in the remaining days of this year.

Joking apart, the middle of the year is a good time to have some reviews. Now, let’s review the U.S. ANDAs received by Chinese pharmaceutical enterprises in the first half of 2019.
Chinese pharmaceutical enterprises have received a total of 41 U.S. ANDA approval numbers in the first half of 2019, which could be called a new high compared to the total of 78 U.S. ANDA approval numbers received in the full 2018.
Application No. | Generic name | Dosage form | Pharmaceutical enterprise name | Approval date/ announcement date |
207494 | Doxycycline hyclate* | Oral delayed-release tablets | Huahai Pharmaceutical | June 20, 2019 |
212017 | Niacin | Oral extended-release tablets | Humanwell Healthcare | June 15, 2019 |
209026 | Potassium chloride | Oral extended-release capsules | Huahai Pharmaceutical | June 11, 2019 |
209826 | Melphalan hydrochloride | Injection | Fosun Pharma | May 28, 2019 |
211007 | Heparin sodium | Injection | Nanjing King-friend | May 28, 2019 |
209333 | Solifenacin succinate | Oral tablets | Qilu Pharmaceutical | May 20, 2019 |
211423 | Solifenacin succinate* | CSPC | Mar. 13, 2019 | |
206062 | Doxorubicin hydrochloride | Injection | Hisun Pharmaceutical | May 13, 2019 |
207375 | Rosuvastatin calcium | Oral tablets | Shandong | May 7, 2019 |
209922 | Read More
Related News
Instruments and Filters for Pharmaceutical Water Treatment Plants
Muhammad Asim Niazi August 4, 2025 You may like
Lamivudine USP Pharmaceutical Pharmaceutical API Antiviral drugs Nucleoside made in china
Ixazomib Citrate; CAS:1201902-80-8
GB/T 38315-2019
Carbadox 98%min Pharmaceutical API Feed additives pharmaceutical excipients made in china
Pharmaceutical nutraceutical OTC drugs dehydrating machine vacuum dryer
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Most popular
The Rise of Biosimilars: Regulatory Pathways and Market Outlook
Nurah Ekhlaque
Sep 19, 2025
Methodology Validation in Chinese Pharmacopoeia 2025: How to Report Accuracy and Precision
Xing Xing
Sep 12, 2025
Digitalization in Procurement: From AI Forecasting to Blockchain Traceability
Saher Haider
Sep 19, 2025
|










(All Rights Reserved)